期刊
NEUROREPORT
卷 18, 期 11, 页码 1187-1191出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/WNR.0b013e32821c56c4
关键词
Alzheimer's disease; amyloid-beta 42 peptides; beta-amyloid precursor protein processing; brain gene expression; cholesterol; inflammatory signaling; lipoprotein receptors; SORLI/LRII; sortilin
资金
- NIA NIH HHS [NIA AG18031] Funding Source: Medline
Sortilin I (SORLI) is a transmembrane sorting receptor that regulates the intracellular trafficking of beta-amyloid precursor protein (beta APP). Interactions between SORLI and PAPP result in the decreased processing of PAPP into toxic amyloid-beta 42 (A beta 42) peptides that accumulate in Alzheimer's disease brain. Here, we report selectively decreased levels of SORLI in limbic and occipital regions of Alzheimer brain that inversely correlate with amyloid plaque and neurofibrillary tangle density. Reduced SORLI, coupled to elevated beta-amyloid cleaving enzyme, presenilin-I and increased A beta 42 peptide secretion, was observed after incubation of cultured human neural cells with the proinflammatory cytokine interleukin-I beta The results suggest that SORLI deficits may not only promote the pathogenic processing of beta APP but may also contribute to A beta 42-mediated inflammatory signaling in stressed human brain cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据